Saliva Offers Unique Benefits and Potentially Wider Applications as a SARS-CoV-2 Specimen
![Saliva based testing for COVID-19 started at Rutgers’ RUCDR Infinite Biologics, where this workstation can process up to 10,000 saliva samples per day. Photo credit: David Sokolowski](https://covid19briefings.com/wp-content/uploads/2020/06/RUCDRDiscovery3-saliva-testing-COVID-19-sm.jpg)
In an exclusive interview, Frederick (Fritz) Kiechle, MD, PhD, explains how and why saliva has emerged as a sample type for detecting SARS-CoV-2, the coronavirus that causes COVID-19.
CDC Provides Additional Supporting Information on New Data Reporting Requirements for Clinical Laboratories
![Clinical laboratories must abide by federal SARS-CoV-2 test reporting requirements.](https://covid19briefings.com/wp-content/uploads/2020/06/AdobeStock_245562438-Converted-SM-1024x658.jpg)
Four important statements from a June 8 CDC clinical laboratory call covering COVID-19 test data reporting requirements.